In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 1.86 below Quanterix Corporation average.

Within Laboratory Analytical Instruments industry 9 other companies have achieved higher Quick Ratio than Quanterix in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 1119 to 1457.

Explain Quick Ratio?
How much Cash & cash equivalents QTRX�s has?
What are QTRX�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

QTRX Quick Ratio	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3	(Jun 30 2025) Q2
Y / Y Current Liabilities Change	4.5 %	23.54 %	77.98 %	112.19 %	14.31 %
Y / Y Cash & cash equivalent Change	-64.19 %	-62.8 %	-59.11 %	-54.07 %	-12.02 %
Quick Ratio MRQ	1.86	1.99	1.58	1.74	5.42
QTRX's Total Ranking	# 1457	# 1119	# 886	# 1091	# 333
Seq. Current Liabilities Change	0.94 %	-33.25 %	-3.35 %	60.47 %	19.33 %
Seq. Cash & cash equivalent Change	-5.78 %	-16.04 %	-12.3 %	-48.38 %	-2.14 %

Quick Ratio second quarter 2026 Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 10
Healthcare Sector	# 515
Overall Market	# 1457

Quick Ratio Statistics
High	Average	Low
36.27	8.4	1.58
(Dec 31 2022)		(Dec 31 2025)

Financial Statements
Quanterix's Current Liabilities	$ 50 Millions	Visit QTRX's Balance sheet
Quanterix's Cash & cash equivalent	$ 94 Millions	Visit QTRX's Balance sheet
Source of QTRX's Sales		Visit QTRX's Sales by Geography

Cumulative Quanterix's Quick Ratio

QTRX's Quick Ratio for the trailling 12 Months

QTRX Quick Ratio	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	51.08 %	55.4 %	51.96 %	30.39 %	5.12 %
Y / Y Cash & cash equivalent TTM Growth	-59.86 %	-46.49 %	-33.89 %	-21.56 %	-10.99 %
Quick Ratio TTM	1.77	2.45	3.24	4.58	6.65
Total Ranking TTM	# 4020	# 3018	# 2163	# 2802	# 2703
Seq. Current Liabilities TTM Growth	0.87 %	3.95 %	15.75 %	24.48 %	3.75 %
Seq. Cash & cash equivalent TTM Growth	-27.33 %	-21.46 %	-17.95 %	-14.29 %	-3.11 %

Quick ratio ranking by company, industry and sector >> Back to QTRX Financial Strength Comparisons >> Go to Compare QTRX Quick Ratio to its Competitors

On the trailing twelve months basis Due to rise in Current Liabilities in the Q2 2026 to $50.37 millions, cumulative Quick Ratio decreased to 1.77 below the Quanterix Corporation average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 21 other companies have achieved higher Quick Ratio than Quanterix. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 3018 to 4020.

Explain Quick Ratio?
How much Cash & cash equivalents QTRX�s has?
What are QTRX�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Laboratory Analytical Instruments Industry	# 22
Healthcare Sector	# 900
Within the Market	# 4020

trailing twelve months Quick Ratio Statistics
High	Average	Low
14.15	6.6	0.59
(Dec 31 2021)		(Jun 30 2026)

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Laboratory Analytical Instruments Industry	Quick Ratio	Jun 30 2026 MRQ Cash & cash equivalent	Jun 30 2026 MRQ Current Liabilities
Scientific Industries Inc	4.92	$ 7.882 Millions	$ 1.602 Millions
Standard Biotools Inc	4.75	$ 270.026 Millions	$ 56.802 Millions
10x Genomics Inc	4.66	$ 552.058 Millions	$ 118.509 Millions
Astrotech Corp	3.72	$ 8.387 Millions	$ 2.257 Millions
Pacific Biosciences Of California Inc	3.44	$ 236.873 Millions	$ 68.806 Millions
Cytek Biosciences Inc	2.83	$ 262.004 Millions	$ 92.698 Millions
Quanterix Corporation	1.86	$ 93.529 Millions	$ 50.373 Millions
Nautilus Biotechnology Inc	1.52	$ 13.166 Millions	$ 8.639 Millions
Rapid Micro Biosystems Inc	1.13	$ 20.500 Millions	$ 18.150 Millions
Bionano Genomics Inc	1.04	$ 10.420 Millions	$ 10.039 Millions
Bio rad Laboratories Inc	0.92	$ 886.900 Millions	$ 961.300 Millions
Precipio inc	0.83	$ 3.075 Millions	$ 3.701 Millions
Lifeloc Technologies Inc	0.83	$ 0.908 Millions	$ 1.099 Millions
Agilent Technologies inc	0.77	$ 1,758.000 Millions	$ 2,289.000 Millions
Revvity Inc	0.67	$ 1,022.943 Millions	$ 1,516.157 Millions

Date modified: 2026-09-08T20:23:06+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.